As shown in Figure 5A, univariate analysis showed that high expression of PSMD2 was significantly correlated with poor overall survival of lung adenocarcinoma patients (HR 1.694, 95%CI, 1.264–2.269, p < 0.001). Here, PSMD2 is linked to lung adenocarcinoma.